Amyotrophic Lateral Sclerosis Clinical Trial
Study data from Georg-August University, Department of Neurology update knowledge of amyotrophic lateral sclerosis clinical trial
Published in Clinical Trials Week, January 22nd, 2007
New investigation results, "Reduced oxidative damage in ALS by high-dose enteral melatonin treatment," are detailed in a study published in Journal of Pineal Research. "Amyotrophic lateral sclerosis (ALS) is the collective term for a fatal motoneuron disease of different etiologies, with oxidative stress as a common molecular denominator of disease progression. Melatonin is an amphiphilic molecule with a unique spectrum of antioxidative effects not conveyed by classical antioxidants," scientists writing in the Journal of Pineal Research report.
"In preparation of a possible future clinical trial, we explored the potential of melatonin as neuroprotective compound...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2007-01-22)
More Articles from Clinical Trials Week
- Chronic Myelogenous Leukemia
Merck, Vertex initiate trial of Aurora kinase inhibitor in treatment-resistant leukemias - Gastric Cancer
Exelixis initiates Phase II trial of XL880 in patients with gastric cancer - Adverse Drug Reactions
Research from Copenhagen University in the area of adverse drug reactions published - Angiogenesis
New angiogenesis in children study findings have been reported by researchers at Friedrich-Alexander University - Angiogenesis
Researchers from Friedrich-Alexander University publish new studies and findings in the area of angiogenesis in children - Atopic Dermatitis Clinical Trial
Studies from University of Pennsylvania further understanding of atopic dermatitis clinical trial - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
